Who are Dex infusion's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Oral Prednisone, Kenalog 10, Kenalog (triamcinolone), Corticosteroids (Prednisone), Celestone + Celestone, corticosteroids (Aprednislon).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dex-infusion.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Dex infusion — Competitive Intelligence Brief

Dex infusion (Dex infusion) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology / Inflammation.

marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology / Inflammation Small molecule Live · refreshed every 30 min

Target snapshot

Dex infusion (Dex infusion) — Seoul National University Hospital. Dexamethasone infusion delivers a corticosteroid systemically to reduce inflammation and suppress immune responses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Dex infusion TARGET	Dex infusion	Seoul National University Hospital	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Oral Prednisone	Oral Prednisone	Assistance Publique - Hôpitaux de Paris	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Kenalog 10	Kenalog 10	The University of Western Australia	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor
Kenalog (triamcinolone)	Kenalog (triamcinolone)	Walter Reed National Military Medical Center	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor
Corticosteroids (Prednisone)	Corticosteroids (Prednisone)	Astellas Pharma Inc	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Celestone + Celestone	Celestone + Celestone	McMaster University	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
corticosteroids (Aprednislon)	corticosteroids (Aprednislon)	Ingrid Pabinger, MD	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
Astellas Pharma Inc · 2 drugs in this class
Sanofi · 2 drugs in this class
Xinqiao Hospital of Chongqing · 2 drugs in this class
Berinstein, Jeffrey · 2 drugs in this class
Ain Shams University · 2 drugs in this class
Children's Hospital of Philadelphia · 1 drug in this class
Celgene · 1 drug in this class
Hamilton Health Sciences Corporation · 1 drug in this class
Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dex infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/dex-infusion. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab